Seriously Cheap26 Jan 2022 16:05
I can't believe this is only £7m mcap
They are cashed up via 10p IPO. Founder money is in at 5p and yet we are trading at 2.7p
The company have an exciting early stage lung cancer detection product in China currently, it is at MOU stage but likely to start offering material royalties soon to CIZ
The deal with SGS is fantastic, their diagnostic test for autoimmune disease will earn them up to £5m in royalties with potential more to come.
I think if we get any sniff of a positive development on something or a deal across the line its fireworks here. Where is the downside? Its a great low risk high reward play from here
I expect to see 10p+ in the monhs ahead